CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide

Journal of Experimental Medicine

Volumn 181, Issue 4, 1995, Pages 1473-1479

  Ingalls, Robin R ^a,b   Golenbock, Douglas T ^a,b  

^a Division of Infectious Diseases   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CD18 ANTIGEN; CELL RECEPTOR; GLYCOPROTEIN P 15095;

ANIMAL CELL; ARTICLE; CHO CELL; GENETIC TRANSFECTION; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA MINNESOTA; SIGNAL TRANSDUCTION;

ANIMAL; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BACTERIAL TOXINS; CHO CELLS; COMPARATIVE STUDY; ENDOTOXINS; HAMSTERS; INTEGRIN ALPHAXBETA2; INTERCELLULAR ADHESION MOLECULE-1; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC; RECOMBINANT FUSION PROTEINS; SALMONELLA; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028909814     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.181.4.1473     Document Type: Article

References (49)

1. Hynes, R.O. 1987. Integrins: a family of cell surface receptors. Cell. 48: 549-554.
2. Anderson, D.C., and T.A. Springer. 1987. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and pl50,95 glycoproteins. Annu. Rev. Med. 38: 175-194.
3. Springer, T.A., L.J. Miller, and D.C. Anderson. 1986. pl50,95, the third number of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family. J. Immunol. 136: 240-245.
4. Sanchez-Madrid, F., J.A. Nagy, E. Robbins, P. Simon, and T.A. Springer. 1983. A human leukocyte differentiation antigen family with distinct a-subunits and a common β-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKMl/Mac-1), and the pl50,95 molecule. J. Exp Med. 158: 1785-1803.
5. Lanier, L.L., M.A. Arnaout, R. Schwarting, N.L. Warner, and G.D. Ross. 1985. pl50/95, third member of the LFA-1/CR3 polypeptide family identified by anti-Leu M5 monoclonal antibody. Eur. J. Immunol. 15: 713-718.
6. Miller, L.J., R. Schwarting, and T.A. Springer. 1986. Regulated expression of the Mac-1, LFA-1, pl50,95 glycoprotein family during leukocyte differentiation. J. Immunol. 137: 2891-2900.
7. Freudenthal, P.S., and R.M. Steinman. 1990. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc. Natl. Acad. Sci. USA. 87: 7698-7702.
8. Stacker, S.A., and T.A. Springer. 1991. Leukocyte integrin P150.95 (CDllc/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium. J. Immunol. 146: 648-655.
9. Loike, J.D., B. Sodeik, L. Cao, S. Leucona, J.I. Weitz, P.A. Detmers, S.D. Wright, and S.C. Silverstein. 1991. CDllc/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. Proc. Natl. Acad. Sci. USA. 88: 1044-1048.
10. Postigo, A.A., A.L. Corbí, F. Sánchez-Madrid, and M.O. de Landazuri. 1991. Regulated expression and function of CDllc/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CDllc/CD18. J. Exp. Med. 174: 1313-1322.
11. Micklem, K.J., and R.B. Sim. 1985. Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of pl50,95 as an iC3b-binding protein. Biochem.J. 231: 233-236.
12. Biisland, C.A., M.S. Diamond, and T.A. Springer. 1994. The leukocyte integrin pl50,95 (CDllc/CD18) as a receptor for iC3b. Activation by a heterologous beta subunit and localization of a ligand recognition site to the I domain. J. Immunol. 152: 4582-4589.
13. Wright, S.D., and M.T.C. Jong. 1986. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp Med. 164: 1876-1888.
14. Wright, S.D., P.A. Detmers, Y. Aida, R. Adamowski, D.C. Anderson, Z. Chad, L.G. Kabbash, and M.J. Pabst. 1990. CD18-deficient cells respond to lipopolysaccharide in vitro. J. Immunol. 144: 2566-2671.
15. Haziot, A.A., S. Chen, E. Ferrero, M.G. Low, R. Silber, and S.M. Goyert. 1988. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141: 547-552.
16. Wright, S.D., R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (Wash. DC). 249: 1431-1433.
17. Schumann, R.R., S.R. Leong, G.W. Flaggs, P.W. Gray, S.D. Wright, J.C. Mathison, P.S. Tobias, and R.J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science (Wash. DC). 249: 1429-1431.
18. Golenbock, D.T., R.Y. Hampton, N. Qureshi, K. Takayama, and C.R.H. Raetz. 1991. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266: 19490-19498.
19. Kirkland, T., N. Qureshi, and K. Takayama. 1991. Diphosphoryl lipid A derived from lipopolysaccharide (LPS) of Rhodopseudomonas sphaeroides inhibits activation of 70Z/3 cells by LPS. Infect. Immun. 59: 131-136.
20. A inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J. Exp Med. 172: 77-84.
21. Takayama, K., N. Qureshi, B. Beutler, and T.N. Kirkland. 1989. Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide. Infect. Immun. 57: 1336-1338.
22. Kitchens, R.L., R.J. Ulevitch, and R.S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp Med. 176: 485-494.
23. Delude, R.L., J.R. Savedra, S. Yamamoto, and D.T. Golenbock. 1995. Use of CD14-transfected cells to study LPS-antagonist action. In Bacterial Endotoxin: Recognition and Effector Mechanisms. Proceedings of the Third Congress of the International Endotoxin Society, Helsinki, August 16-19, 1994. J. Levin, editor. Elsevier Science Publishers, Amsterdam. In press.
24. Diamond, M.S., J. Garcia-Aguilar, J.K. Bickford, A.L. Corbi, and T.A. Springer. 1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CDllb/CD18) for four distinct adhesion ligands. J. Cell Biol. 120: 1031-1043.
25. Golenbock, D., Y. Liu, F. Millham, M. Freeman, and R. Zoeller. 1993. Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J. Biol. Chem. 268: 22055-22059.
26. Delude, R.L., M.J. Fenton, R. Savedra, P.-Y. Perera, S. Vogel, and D.T. Golenbock. 1994. CD14-mediated translocation of NF-kB induced by LPS does not require tyrosine kinase activity. J. Biol. Chem. 269: 22252-22260.
27. Libermann, T.A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 10: 2327-2334.
28. Shakhov, A.N., M.A. Collart, P. Vassalli, S.A. Nedospasov, and C.V. Jongeneel. 1990. κ B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor a gene in primary macrophages. J. Exp. Med. 171: 35-47.
29. Shimizu, H., K. Mitomo, T. Watanabe, S. Okamoto, and K. Yamamoto. 1990. Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol. Cell. Biol. 10: 561-568.
30. Sanchez-Madrid, F., A.M. Krensky, C.F. Ware, E. Robbins, J.L. Strominger, S.J. Burakoff, and T.A. Springer. 1982. Three distinct antigens associated with human T lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl. Acad. Sci. USA. 79: 7489-7493.
31. Uciechowski, P., and R. Schmidt. 1989. Cluster report: CDllc. In Leukocyte Typing IV: White Cell Differentiation Antigens. W. Knapp, B. Dorken, W. Gilks, E. Rieber, R. Schmidt, H. Stein, and A. von dem Borne, editors. Oxford University Press, Oxford. 543-551.
32. Urlaub, G., P.J. Mitchell, E. Kas, L.A. Chasin, V.L. Funanage, T.T. Myoda, and J. Hamlin. 1986. Effect of gamma rays at the dihidrofolate reductase locus: deletions and inversions. Somatic Cell Mol. Genet. 12: 555-566.
33. Diamond, M.S., and T.A. Springer. 1993. A subpopulation of Mac-1 (CDllb/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell Biol. 120: 545-556.
34. Goldblum, S.E., T.W. Brann, X. Ding, J. Pugin, and P.S. Tobias, 1994. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro, f. Clin. Invest. 93: 692-702.
35. Hailman, E., H.S. Lichenstein, M.M. Wurfel, D.S. Miller, D.A. Johnson, M. Kelley, L.A. Busse, M.M. Zukowski, and S.D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp Med 179: 269-277.
36. Wright, S.D., R.A. Ramos, M. Patel, and D.S. Miller. 1992. Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes. J. Exp Med. 176: 719-727.
37. Frey, E.A., D.S. Miller, T.G. Jahr, A. Sundan, V. Bazil, T. Espevik, B.B. Finlay, and S.D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. f. Exp Med. 176: 1665-1671.
38. Arditi, M., J. Zhou, R. Dorio, G.W. Rong, S.M. Goyert, and K.S. Kim. 1993. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect. Immun. 61: 3149-3156.
39. Pugin, J., C.C. Schurer-Maly, D. Leturcq, A. Moriarty, R.J. Ulevitch, and P.S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA. 90: 2744-2748.
40. Read, M.A., S.R. Cordle, R.A. Veach, C.D. Carlisle, and J. Hawiger. 1993. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl. Acad. Sci. USA. 90: 9887-9891.
41. Haziot, A., G.W. Rong, J. Silver, and S.M. Goyert. 1993. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151: 1500-1507.
42. Wright, S.D., P.S. Tobias, R.J. Ulevitch, and R.A. Ramos. 1989. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170: 1231-1241.
43. Fuhlbrigge, R.C., D.D. Chaplin, J.M. Kiely, and E.R. Unanue. 1987. Regulation of interleukin 1 gene expression by adherence and lipopolysaccharide. J. Immunol. 138: 3799-3802.
44. Couturier, C., N. Haeffner-Cavaillon, L. Weiss, E. Fischer, and M.D. Kazatchkine. 1990. Induction of cell-associated interleukin 1 through stimulation of the adhesion-promoting proteins LFA-1 (CDUa/CD18) and CR3 (CDllb/CD18) of human monocytes. Eur. J. Immunol. 20: 999-1005.
45. Berton, G., C. Laudanna, C. Sorio, and F. Rossi. 1992. Generation of signals activating neutrophil functions by leukocyte integrins: LFA-1 and gpl50/95, but not CR3, are able to stimulate the respiratory burst of human neutrophils. J. Cell Biol. 116: 1007-1017.
46. Lacal, P.M., J. Balsinde, C. Cabanas, C. Bernabeu, F. Sanchez-Madrid, and F. Mollinedo. 1990. The CDllc antigen couples concanavalin A binding to generation of superoxide anion in human phagocytes. Biochem. J. 268: 707-712.
47. Wright, S.D. 1991. Multiple receptors for endotoxin. Curr. Opin. Immunol. 3: 83-90.
48. Lynn, W.A., Y. Liu, and D.T. Golenbock. 1993. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide. Infect. Immun. 61: 4452-4461.
49. Haziot, A., E. Ferrero, X. Lin, C. Stewart, and S.M. Goyert. 1994. CD14-negative mice: analysis of the response to LPS. J. Endotoxin Res. 1 (Suppl. 1): C136 (Abstr.)